secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001613103-24-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q3 FY2024: Revenue $8.1B, GAAP EPS $0.99, raises FY24 guidance; exits ventilator business
--------------------------------------------------------------------------------

- Q3 revenue $8.089B, up 4.7% reported and 4.6% organic; GAAP EPS $0.99, non-GAAP EPS $1.30.
- Raises FY24 organic revenue growth guidance to 4.75%-5% and non-GAAP EPS to $5.19-$5.21.
- Exiting ventilator product line; combining PMRI into Acute Care & Monitoring unit.
- EVP Robert J. White to leave April 26, 2024 due to organizational changes.
- Diabetes revenue $640M, up 12.3%, U.S. returns to growth; CE Mark for MiniMed 780G with Simplera Sync.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310324000006/0001613103-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310324000006/mdt-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001613103-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer